tirzepatide in pills F.D.A. Approves New Obesity Drug
Description
Although retatrutide is showing promising results in clinical trials, it has not yet been FDA approved, so conclusions cant be made around it being the best weight loss solution
M., Nikooienejad A., Robins D
*Eligible patients lost an average of 21% of their body weight (-48 lbs) in a 72-week clinical trial evaluating 15 mg tirzepatide, when paired with diet and exercise
Different populations
If in doubt, follow your anaesthetists fasting guidance precisely rather than relying on generic internet timelines
